Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Clearone (CLRO) Asset Writedowns and Impairment: 2010-2025

Historic Asset Writedowns and Impairment for Clearone (CLRO) over the last 14 years, with Jun 2025 value amounting to $48,000.

  • Clearone's Asset Writedowns and Impairment rose 150.53% to $48,000 in Q2 2025 from the same period last year, while for Jun 2025 it was $1.5 million, marking a year-over-year increase of 436.10%. This contributed to the annual value of $1.1 million for FY2024, which is 283.99% up from last year.
  • As of Q2 2025, Clearone's Asset Writedowns and Impairment stood at $48,000, which was down 82.35% from $272,000 recorded in Q1 2025.
  • Clearone's 5-year Asset Writedowns and Impairment high stood at $1.2 million for Q4 2024, and its period low was -$101,000 during Q4 2022.
  • For the 3-year period, Clearone's Asset Writedowns and Impairment averaged around $186,500, with its median value being $64,000 (2023).
  • The largest annual percentage gain for Clearone's Asset Writedowns and Impairment in the last 5 years was 739.13% (2024), contrasted with its biggest fall of 300.00% (2024).
  • Clearone's Asset Writedowns and Impairment (Quarterly) stood at $52,000 in 2021, then slumped by 294.23% to -$101,000 in 2022, then skyrocketed by 274.26% to $176,000 in 2023, then soared by 565.34% to $1.2 million in 2024, then spiked by 150.53% to $48,000 in 2025.
  • Its Asset Writedowns and Impairment stands at $48,000 for Q2 2025, versus $272,000 for Q1 2025 and $1.2 million for Q4 2024.